Gazelle Diagnostic Device

Hemex Health Inc

Gazelle diagnostic device is a non-invasive sickle cell and malaria diagnostic device 


Product description Brand name and product description

Gazelle is a compact, rugged, and portable battery-operated point-of-care test diagnostic device for anemia and sickle cell disease (SCD) with results in just minutesThere are two variants of the device, the Gazelle Hb Variant and the Gazelle malaria. A commercialized tool for anemia is being developed with the goal of a one-minute 25-cent noninvasive diagnostic tool for screening anemia, malaria, and SCD using an optical finger sensor. 

Target region(s) Target region for distribution/implementation (listed by country if specified)
Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

The product is distributed by the following institutions: Hemex Health, HemexDx  Case Western Reserve University, Novartis Biome,Tata Elxsi, Bio-Rad Laboratories 


Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

At the factory, the reader costs between 800 USD and 1,200 USD, while the cartridges range from 1 USD to 3 USD. The cost of the test with the device is about one dollar per test. The price after delivery and shipping can sometimes cost about twice the factory price. Interview with representative

Competitive landscape Similar products available on the market. May not be a comprehensive listing.
SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: Good health and well-being


Target user(s) Target user/consumer base (country, income segment)
The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects